US Patent Issued to Oklahoma Medical Research Foundation, The Board of Regents of the University of Oklahoma on Sept. 15 for "Antibody tests for identifying Ro negative Sjogren's Syndrome and use as biomarkers for dysregulated B cell responses, B cell lymphoma, tissue fibrosis and salivary gland dysfunction" (Oklahoma Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,736,533, issued on Sept. 15, was assigned to Oklahoma Medical Research Foundation (Oklahoma City) and The Board of Regents of the University of Oklahoma (Norman, Okla.).

"Antibody tests for identifying Ro negative Sjogren's Syndrome and use as biomarkers for dysregulated B cell responses, B cell lymphoma, tissue fibrosis and salivary gland dysfunction" was invented by A. Darise Farris (Edmond, Okla.) and Sherri Longobardi (Oklahoma City).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention includes a method and kit of determining that a patient negative for anti-Ro autoantibodies has Sjogren's syndrome (SS) without performing a lip biops...